The Pharmasyntez Group, one of three fastest developing Russian pharmaceutical companies, and German company Bausch+Ströbel, a leader in pharmaceutical equipment production, signed a contract at the the 29th International special pharmaceutical industry exhibition CPhI Worldwide Madrid, 2018.
The subject of the contract is supply of a new equipment, the combination filling line for vials and cartridges, the most up-to-date, high technology and high-performance line in the world, to the Group’s subsidiary Pharmasyntez-Nord in Saint Petersburg.
“JSC Pharmasyntez commits itself to the production of modern drugs, including innovative ones”, Vikram Punia, President of the Pharmasyntez Group, noted after signing the contract with Bausch+Ströbel. “Our aim is high quality products, and that is why we conclude contracts with world renowned suppliers of pharmaceutical equipment that is of tried-and-true quality and meets all current GMP requirements”.
Earlier this year Pharmasyntez signed a number of contracts on supply of high-performance pharmaceutical equipment with such leading European manufacturers as GEA (Belgium), Romaco (Germany), Bosch (Germany) for a total amount of several billion rubles which goes to show that the company is one of the major investors in pharmaceutical industry.
As Denis Manturov, Minister of Industry and Trade of the Russian Federation, said during his visit to China in September 2018, export of Russian pharmaceuticals would grow massively in the nearest future and in five years it would reach 3 to 4 billion US dollars per year due to the production of innovative drugs. JSC Pharmasyntez is all for the economic development thrust set by the Russian government.